Danimar: medical device for nasal congestion and mucosal health
Chronic nasal congestion and respiratory conditions associated with impaired mucociliary clearance significantly impact quality of life. Symptoms such as obstruction, thick secretions, and facial pressure require targeted solutions. In this context, using a specific product like Danimar, a medical device for nasal congestion, is essential for restoring proper respiratory function.
According to the EPOS 2020 international guidelines, the management of sinonasal symptoms must utilize validated clinical measurement tools to assess therapeutic impact. Among these, the Sino-Nasal Outcome Test (SNOT-22) is one of the most widely used questionnaires globally in Otolaryngology.
The data presented refers to an observational clinical study conducted by Gruppo farmaImpresa in June 2025. The research evaluated the efficacy of the Danimar medical device in managing chronic nasal congestion.
Danimar Clinical Study: Efficacy and SNOT-22
Farmaimpresa Group conducted a prospective observational clinical study to evaluate the performance of Danimar (FT.CE.115), a nasal spray based on hyaluronic acid in a hypertonic NaCl solution.
Study Methodology
The study involved 20 adult patients (age range 14-73) over a 2-week treatment period. Efficacy was measured using the SNOT-22 test, which analyzes 22 clinical parameters across key areas:
- Physical Symptoms: Nasal obstruction, rhinorrhea, and thick secretions.
- Sensory Symptoms: Facial pressure/pain and olfactory changes.
- Systemic Impact: Sleep disturbance, fatigue, and emotional/functional well-being.
Key Results
The data collected showed a significant reduction in the SNOT-22 score. This confirms that the Danimar medical device for nasal congestion not only supports mechanical decongestion but also promotes re-epithelialization and deep mucosal hydration thanks to hyaluronic acid.
Who is Danimar Indicated For?
Thanks to its balanced formulation, Danimar is the ideal support for:
- Acute and chronic nasal congestion.
- Mucosal dryness (caused by external factors or pharmacological use).
- Rhinitis (both allergic and non-allergic).
- Rhinosinusitis and inflammation of the paranasal sinuses.
- Impaired mucociliary clearance, to facilitate the expulsion of excess mucus.
We are a leader in providing ready-to-market lines in the medical device, food supplement, cosmetic, and aesthetic medicine sectors. Building on the success of products like Danimar, we offer our partners “turnkey” solutions that combine clinical rigor with rapid market entry.
Advantages of Our Ready-to-Market Line:
Immediate Time-to-Market: Products are already formulated, tested, and ready for your catalog.
- Validated Efficacy: Every reference, as demonstrated by the Danimar study, is backed by solid clinical data.
- High Regulatory Standards: Certifications are already in place to ensure maximum distribution security.
- Scientific Know-how: Leverage our expertise to offer superior products to your customers.
Would you like to become a distributor and discover our ready-to-market products?
